Published in Biotech Business Week, November 29th, 2004
The Intelligent Dosing System (IDS) incorporates patient-specific dosing data into a proprietary model that calculates the optimal next dose needed to achieve a desired target level or goal.
The IDS requires only two prior dose and response inputs to calculate the optimal next dose and is effective in the simultaneous dosing of multiple agents.
The company is in active discussions regarding the utilization of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.